GURPREET SAINI: Open Payments
NPI 1326582396 · SALEM, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$171 in 7 payments from 6 companies in 2025. Trend: 2023 $217 · 2024 $46 · 2025 $171
Food & beverage: $171
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $33 |
| Novo Nordisk Inc | 2 | $33 |
| Novartis Pharmaceuticals Corporation | 1 | $32 |
| Indivior Inc. | 1 | $29 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $28 |
| Currax Pharmaceuticals LLC | 1 | $15 |
Products named: JARDIANCE, LEQVIO, SUBLOCADE, JOURNAVX, Ozempic, CONTRAVE, Wegovy.
Industry payments across MA — which companies pay providers there.
